跳至主要内容
临床试验/JPRN-jRCT1051210161
JPRN-jRCT1051210161招募中4 期

Epidemiological study on changes in immune response after two doses of COVID-19 vaccination

Kayeka Hiroshi0 个研究点目标入组 600 人开始时间: 2022年1月23日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Those who meet all of the following 1) to 6)
  • 1) Persons who meet any of the following (a), (b) and (c)
  • (a) Participants of Prospective cohort study of effectiveness and safety of COVID-19 vaccines in Osaka, Japan *
  • (b) Staff of Osaka City (Metropolitan) University Hospital
  • (c) Faculty / Students of Osaka City (Metropolitan) University School of Medicine / Graduate School of Medicine
  • * Approval number by Osaka City (Metropolitan) University Hospital Certified Review Board: OCU010E, jRCT registration number: jRCT105120014
  • 2) Aged 20 years or older
  • 3) Those who have received two doses of COVID-19 vaccines
  • 4) Those who have passed 5 months since the second dose of COVID-19 vaccines
  • 5) Those who are expected to be able to provide their blood in a predefined number of times during the study period
  • 6) Persons who have voluntarily provided written informed consent for participation

排除标准

  • Persons who meet any of the following 1) 2)
  • 1) Those who have received pre-licensure COVID-19 vaccines in the past (e.g., participation in clinical trials before licensure)
  • 2) Those who are judged to be ineligible for research by the principal investigator or the investigator

研究者

发起方
Kayeka Hiroshi

相似试验